GARDEN BIO-CHEM(300401)2022-10-21 16:00Financial Performance - The company's operating revenue for Q3 2022 reached ¥277,714,779.46, representing a 17.93% increase compared to ¥106,084,487.92 in the same period last year[6] - The net profit attributable to shareholders for Q3 2022 was ¥56,752,880.16, a 7.85% increase from ¥40,729,866.67 in the previous year[6] - The net profit excluding non-recurring gains and losses was ¥54,368,127.47, marking a 40.58% increase from ¥38,674,059.36 year-on-year[6] - Total operating revenue for the current period reached ¥1,078,266,939.50, a significant increase from ¥768,090,617.40 in the previous period, representing a growth of approximately 40.4%[33] - Net profit attributable to shareholders of the parent company was ¥353,789,983.54, down from ¥371,982,083.60, reflecting a decrease of approximately 4.3%[36] - The total profit for the current period was ¥411,925,580.34, down from ¥459,816,352.85, representing a decrease of about 10.4%[33] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,525,311,449.31, reflecting a 16.06% increase from the previous year[6] - As of September 30, 2022, current assets totaled approximately CNY 1.46 billion, an increase of 31.7% from CNY 1.11 billion on January 1, 2022[26] - Total liabilities reached CNY 1.51 billion, a 20.9% increase from CNY 1.25 billion[29] - The company's total equity increased to CNY 2.58 billion from CNY 2.28 billion, reflecting a growth of 13.4%[29] - The total assets of the company reached CNY 4.09 billion, compared to CNY 3.53 billion, showing a growth of 15.9%[29] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥371,080,631.51, a decrease of 14.55% compared to ¥434,288,162.19 last year[6] - Cash inflow from operating activities totaled ¥1,303,291,013.69, an increase from ¥1,085,719,932.27, indicating a growth of about 20.1%[37] - Net cash flow from operating activities was CNY 371,080,631.51, a decrease of 14.5% compared to CNY 434,288,162.19 in the previous period[40] - Total cash outflow from operating activities reached CNY 932,210,382.18, up 43% from CNY 651,431,770.08[40] - Cash inflow from financing activities totaled CNY 721,564,530.00, an increase of 145.2% compared to CNY 293,500,122.75[40] Expenses - The sales expenses for Q3 2022 surged to ¥251,889,368.98, a significant increase of 161.98% from ¥96,150,127.24 in the previous year[15] - Total operating costs increased to ¥715,104,420.69 from ¥430,082,050.16, marking a rise of about 66.5%[33] - Research and development expenses rose to ¥43,658,283.82 from ¥37,377,750.80, an increase of approximately 16.8%[33] - Cash paid for purchasing goods and services increased by 33.25% to ¥413,630,028.77, reflecting higher operating income and corresponding increases in production material purchases[16] Shareholder Information - The total number of common shareholders at the end of the reporting period was 17,358[18] - The company initiated an employee stock ownership plan, repurchasing 7,674,790 shares at a price of ¥7.00 per share[22] Investments and Financing - The company obtained bank loans amounting to ¥665,996,000.00, a significant increase of 156.15% compared to the previous period[16] - The company is in the process of issuing convertible bonds, with the application currently under review by the Shenzhen Stock Exchange[21] Other Income and Tax - The company reported a decrease in other income by 51.49%, totaling ¥24,974,596.29 compared to ¥51,481,301.87 last year[15] - The company reported a total tax payment of CNY 140,166,812.05, an increase of 23.2% from CNY 113,743,319.95[40]